×

Chemed Profit Margin 2010-2024 | CHE

Current and historical gross margin, operating margin and net profit margin for Chemed (CHE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chemed net profit margin as of September 30, 2024 is 12.69%.
Chemed Annual Profit Margins
Chemed Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.944B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.436B 11.76
Quest Diagnostics (DGX) United States $16.851B 17.08
DaVita (DVA) United States $12.283B 15.88
Encompass Health (EHC) United States $9.311B 21.95
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.257B 116.43
Option Care Health (OPCH) United States $3.856B 18.27
Amedisys (AMED) United States $2.964B 21.09
LifeStance Health (LFST) United States $2.832B 0.00
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $1.799B 24.60
U.S Physical Therapy (USPH) United States $1.347B 35.41
Pennant (PNTG) United States $0.901B 36.42
Aveanna Healthcare Holdings (AVAH) United States $0.883B 0.00
Atai Life Sciences (ATAI) Germany $0.227B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00